Used as a key intermediate in the synthesis of xanthine oxidase inhibitors, particularly in the production of drugs like febuxostat, which is prescribed for the management of gout and hyperuricemia. Its structure allows for selective inhibition of uric acid formation by targeting the enzyme responsible for purine metabolism. It is valued in pharmaceutical development for its reactivity and ability to form stable derivatives with enhanced bioavailability. Commonly employed in research settings for designing new heterocyclic compounds with potential anti-inflammatory and antioxidant properties.